Regulation 26 Defences and exceptions
Administration is in accordance with this regulation if—
it is of a veterinary medicinal product containing oestradiol 17β, testosterone or progesterone or a derivative of any of these substances which readily yields the parent compound or hydrolysis after absorption at the site of application; and
it is carried out for a therapeutic purpose on a clearly identified farm animal by a veterinary surgeon, who makes an appropriate record of the treatment, by injection or for the treatment (other than by implant) of ovarian dysfunction in the form of vaginal spirals.
For the purposes of paragraph (1)(b) above and regulation 28(c) “appropriate record”means the entry in a register of the following details—
type of treatment;
the type of products authorised or prescribed;
the date of treatment;
the identity of the animals treated; and
any applicable withdrawal period.